Case Report: Prolonged VV-ECMO (111 Days) Support in a Patient With Severe COVID-19

Venovenous extracorporeal membrane oxygenation (VV-ECMO) may be a lifesaving rescue therapy for patients with severe coronavirus disease 2019 (COVID-19). However, little is known regarding the efficacy of prolonged ECMO (duration longer than 14 days) in patients with COVID-19. In this case report, w...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Zhiheng, Xu, Yonghao, Liu, Dongdong, Liu, Xuesong, Zhou, Liang, Huang, Yongbo, Li, Yimin, Liu, Xiaoqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8374894/
https://www.ncbi.nlm.nih.gov/pubmed/34422856
http://dx.doi.org/10.3389/fmed.2021.681548
_version_ 1783740213068038144
author Xu, Zhiheng
Xu, Yonghao
Liu, Dongdong
Liu, Xuesong
Zhou, Liang
Huang, Yongbo
Li, Yimin
Liu, Xiaoqing
author_facet Xu, Zhiheng
Xu, Yonghao
Liu, Dongdong
Liu, Xuesong
Zhou, Liang
Huang, Yongbo
Li, Yimin
Liu, Xiaoqing
author_sort Xu, Zhiheng
collection PubMed
description Venovenous extracorporeal membrane oxygenation (VV-ECMO) may be a lifesaving rescue therapy for patients with severe coronavirus disease 2019 (COVID-19). However, little is known regarding the efficacy of prolonged ECMO (duration longer than 14 days) in patients with COVID-19. In this case report, we report the successful use of prolonged VV-ECMO (111 days) in a 61-year-old man with severe COVID-19. Given the high mortality rate of severe COVID-19, this case provided evidence for use of prolonged VV-ECMO as supportive care in patients with severe COVID-19.
format Online
Article
Text
id pubmed-8374894
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-83748942021-08-20 Case Report: Prolonged VV-ECMO (111 Days) Support in a Patient With Severe COVID-19 Xu, Zhiheng Xu, Yonghao Liu, Dongdong Liu, Xuesong Zhou, Liang Huang, Yongbo Li, Yimin Liu, Xiaoqing Front Med (Lausanne) Medicine Venovenous extracorporeal membrane oxygenation (VV-ECMO) may be a lifesaving rescue therapy for patients with severe coronavirus disease 2019 (COVID-19). However, little is known regarding the efficacy of prolonged ECMO (duration longer than 14 days) in patients with COVID-19. In this case report, we report the successful use of prolonged VV-ECMO (111 days) in a 61-year-old man with severe COVID-19. Given the high mortality rate of severe COVID-19, this case provided evidence for use of prolonged VV-ECMO as supportive care in patients with severe COVID-19. Frontiers Media S.A. 2021-08-05 /pmc/articles/PMC8374894/ /pubmed/34422856 http://dx.doi.org/10.3389/fmed.2021.681548 Text en Copyright © 2021 Xu, Xu, Liu, Liu, Zhou, Huang, Li and Liu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Xu, Zhiheng
Xu, Yonghao
Liu, Dongdong
Liu, Xuesong
Zhou, Liang
Huang, Yongbo
Li, Yimin
Liu, Xiaoqing
Case Report: Prolonged VV-ECMO (111 Days) Support in a Patient With Severe COVID-19
title Case Report: Prolonged VV-ECMO (111 Days) Support in a Patient With Severe COVID-19
title_full Case Report: Prolonged VV-ECMO (111 Days) Support in a Patient With Severe COVID-19
title_fullStr Case Report: Prolonged VV-ECMO (111 Days) Support in a Patient With Severe COVID-19
title_full_unstemmed Case Report: Prolonged VV-ECMO (111 Days) Support in a Patient With Severe COVID-19
title_short Case Report: Prolonged VV-ECMO (111 Days) Support in a Patient With Severe COVID-19
title_sort case report: prolonged vv-ecmo (111 days) support in a patient with severe covid-19
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8374894/
https://www.ncbi.nlm.nih.gov/pubmed/34422856
http://dx.doi.org/10.3389/fmed.2021.681548
work_keys_str_mv AT xuzhiheng casereportprolongedvvecmo111dayssupportinapatientwithseverecovid19
AT xuyonghao casereportprolongedvvecmo111dayssupportinapatientwithseverecovid19
AT liudongdong casereportprolongedvvecmo111dayssupportinapatientwithseverecovid19
AT liuxuesong casereportprolongedvvecmo111dayssupportinapatientwithseverecovid19
AT zhouliang casereportprolongedvvecmo111dayssupportinapatientwithseverecovid19
AT huangyongbo casereportprolongedvvecmo111dayssupportinapatientwithseverecovid19
AT liyimin casereportprolongedvvecmo111dayssupportinapatientwithseverecovid19
AT liuxiaoqing casereportprolongedvvecmo111dayssupportinapatientwithseverecovid19

Ejemplares similares